Total Payments
$410,492
2024 Payments
$16,317
Companies
38
Transactions
709
Medicare Patients
4,634
Medicare Billing
$303,000
Payment Breakdown by Category
Other$320,956 (78.2%)
Travel$67,870 (16.5%)
Food & Beverage$15,263 (3.7%)
Consulting$6,343 (1.5%)
Education$60.68 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $320,956 | 155 | 78.2% |
| Travel and Lodging | $67,870 | 112 | 16.5% |
| Food and Beverage | $15,263 | 431 | 3.7% |
| Consulting Fee | $6,343 | 3 | 1.5% |
| Education | $60.68 | 8 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $245,418 | 311 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $82,240 | 115 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $37,473 | 82 | $0 (2019) |
| Bayer Healthcare Pharmaceuticals Inc. | $19,779 | 22 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $12,989 | 42 | $0 (2023) |
| MannKind Corporation | $8,061 | 23 | $0 (2023) |
| Medtronic, Inc. | $1,670 | 14 | $0 (2024) |
| Medtronic MiniMed, Inc. | $395.10 | 4 | $0 (2020) |
| Lilly USA, LLC | $359.28 | 23 | $0 (2024) |
| Amgen Inc. | $321.00 | 13 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $16,317 | 66 | Bayer Healthcare Pharmaceuticals Inc. ($11,565) |
| 2023 | $11,506 | 36 | Novo Nordisk Inc ($9,616) |
| 2022 | $51,117 | 50 | Novo Nordisk Inc ($38,195) |
| 2021 | $35,071 | 42 | Novo Nordisk Inc ($24,818) |
| 2020 | $33,295 | 38 | AstraZeneca Pharmaceuticals LP ($17,819) |
| 2019 | $64,963 | 91 | Novo Nordisk Inc ($46,725) |
| 2018 | $74,733 | 139 | Novo Nordisk Inc ($46,760) |
| 2017 | $123,490 | 247 | Novo Nordisk Inc ($60,408) |
All Payment Transactions
709 individual payment records from CMS Open Payments — Page 1 of 29
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Travel and Lodging | In-kind items and services | $759.52 | General |
| Category: Cardio-renal | ||||||
| 12/12/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,273.00 | General |
| Category: Cardio-renal | ||||||
| 12/10/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $24.50 | General |
| Category: Cardio-renal | ||||||
| 12/10/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $20.53 | General |
| Category: NEUROLOGY | ||||||
| 12/06/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Travel and Lodging | In-kind items and services | $759.28 | General |
| Category: Cardio-renal | ||||||
| 12/05/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $85.47 | General |
| Category: Cardio-renal | ||||||
| 11/22/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $18.06 | General |
| Category: EPILEPSY | ||||||
| 11/21/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,785.00 | General |
| Category: Cardio-renal | ||||||
| 11/21/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $16.09 | General |
| Category: RESPIRATORY | ||||||
| 11/19/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $22.20 | General |
| Category: NEUROLOGY | ||||||
| 11/14/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $22.19 | General |
| Category: Neurology | ||||||
| 11/12/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $8.85 | General |
| Category: NEUROLOGY | ||||||
| 11/07/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $21.02 | General |
| Category: Rare Disease | ||||||
| 10/16/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: NEUROLOGY | ||||||
| 10/09/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $78.20 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/07/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $10.60 | General |
| Category: Cardio-renal | ||||||
| 09/25/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $22.88 | General |
| Category: Diabetes | ||||||
| 09/17/2024 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $158.07 | General |
| Category: Durable Pump | ||||||
| 09/11/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $16.08 | General |
| Category: Neuropsychiatry | ||||||
| 09/10/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $19.92 | General |
| Category: Rare Disease | ||||||
| 09/06/2024 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $19.23 | General |
| Category: Durable Pump | ||||||
| 09/03/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $21.98 | General |
| Category: Cardio-renal | ||||||
| 08/28/2024 | Aucta Pharmaceuticals, Inc. | Motpoly XR (Drug) | Food and Beverage | In-kind items and services | $11.34 | General |
| Category: Central Nervous System | ||||||
| 08/27/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $3.80 | General |
| Category: NEUROLOGY | ||||||
| 08/13/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $22.97 | General |
| Category: NEUROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 943 | 1,352 | $242,984 | $65,027 |
| 2022 | 9 | 1,119 | 1,619 | $288,843 | $81,233 |
| 2021 | 9 | 1,053 | 1,398 | $292,403 | $80,149 |
| 2020 | 11 | 1,519 | 1,883 | $308,544 | $76,592 |
Total Patients
4,634
Total Services
6,252
Medicare Billing
$303,000
Procedure Codes
39
All Medicare Procedures & Services
39 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 247 | 375 | $104,076 | $31,299 | 30.1% |
| 95250 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with provider supplied equipment | Office | 2023 | 96 | 118 | $64,514 | $11,778 | 18.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 112 | 128 | $25,088 | $7,283 | 29.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 34 | 38 | $14,765 | $4,835 | 32.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 30 | 30 | $12,402 | $3,546 | 28.6% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 180 | 282 | $9,330 | $2,685 | 28.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 17 | 17 | $8,396 | $2,237 | 26.6% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 205 | 342 | $3,577 | $1,095 | 30.6% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 11 | 11 | $550.00 | $177.00 | 32.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 11 | 11 | $286.00 | $92.40 | 32.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 242 | 383 | $106,474 | $34,704 | 32.6% |
| 95250 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with provider supplied equipment | Office | 2022 | 88 | 107 | $57,031 | $11,111 | 19.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 141 | 171 | $33,516 | $9,839 | 29.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 73 | 73 | $30,544 | $8,002 | 26.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 49 | 58 | $22,504 | $7,770 | 34.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 30 | 30 | $14,975 | $3,920 | 26.2% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 197 | 293 | $10,548 | $2,804 | 26.6% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2022 | 61 | 69 | $8,901 | $1,679 | 18.9% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2022 | 238 | 435 | $4,350 | $1,404 | 32.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 191 | 297 | $80,649 | $26,214 | 32.5% |
| 95250 | Ambulatory continuous glucose (sugar) monitoring for a minimum of 72 hours | Office | 2021 | 131 | 152 | $81,016 | $15,899 | 19.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 90 | 90 | $36,840 | $10,717 | 29.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 132 | 155 | $28,556 | $9,314 | 32.6% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 35 | 35 | $17,559 | $5,920 | 33.7% |
| 95251 | Ambulatory continuous glucose (sugar) including interpretation and report for a minimum of 72 hours | Office | 2021 | 150 | 196 | $25,284 | $5,112 | 20.2% |
About Dr. Alfred Okeke, MD
Dr. Alfred Okeke, MD is a Endocrinology, Diabetes & Metabolism healthcare provider based in Goldsboro, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1093753436.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Alfred Okeke, MD has received a total of $410,492 in payments from pharmaceutical and medical device companies, with $16,317 received in 2024. These payments were reported across 709 transactions from 38 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($320,956).
As a Medicare-enrolled provider, Okeke has provided services to 4,634 Medicare beneficiaries, totaling 6,252 services with total Medicare billing of $303,000. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.
Ad
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism
- Location Goldsboro, NC
- Active Since 06/04/2006
- Last Updated 09/29/2022
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1093753436
Products in Payments
- Ozempic (Drug) $78,244
- FARXIGA (Drug) $78,187
- Tresiba (Drug) $56,194
- INVOKANA (Drug) $37,504
- Rybelsus (Drug) $26,108
- RYBELSUS (Drug) $22,548
- Xultophy 100/3.6 (Drug) $21,778
- Kerendia (Drug) $19,779
- SOLIQUA (Drug) $9,744
- Victoza (Drug) $9,352
- AFREZZA (Drug) $8,061
- BYDUREON (Drug) $4,000
- TOUJEO (Drug) $2,841
- MINIMED 780G (Device) $1,670
- Minimed 670G System (Device) $395.10
- JARDIANCE (Drug) $245.85
- Xultophy (Drug) $220.00
- ZEGALOGUE (Drug) $207.34
- SOLIQUA 100/33 (Biological) $188.84
- Prolia (Biological) $176.96
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.